We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BTCY market cap is 14.82M. The company's latest EPS is USD -0.6649 and P/E is -0.62.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.89M | 2.97M | 3.18M | 3.2M | 3.27M |
| Operating Income | -1.63M | -2.86M | -1.47M | -1.12M | -308k |
| Net Income | -3.88M | -3.05M | -4.4M | -6.95M | -1.65M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.42M | 3.39M | 7.65M | 9.64M | 12.06M |
| Operating Income | -10.93M | -13.35M | -18.02M | -15.41M | -8.83M |
| Net Income | -11.33M | -16.45M | -30.22M | -19.53M | -14.93M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.82M | 5.49M | 5.94M | 5.42M | 5.29M |
| Total Liabilities | 32.3M | 32.21M | 35.92M | 33.02M | 34.17M |
| Total Equity | -26.73M | -27.76M | -31.47M | -29.78M | -31.17M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2M | 4.44M | 16.68M | 6.51M | 5.94M |
| Total Liabilities | 5.01M | 11.27M | 18.82M | 26.36M | 35.92M |
| Total Equity | -3M | -6.83M | -2.15M | -19.85M | -31.47M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.22M | -5.53M | -6.69M | -1.49M | -1.89M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 4.76M | 4.95M | 6.74M | 868k | 1.34M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.86M | -11.08M | -15.16M | -13.55M | -6.69M |
| Investing | N/A | N/A | -30k | N/A | N/A |
| Financing | 8.88M | 12.2M | 25.17M | 2M | 6.74M |
| Market Cap | 14.82M |
| Price to Earnings Ratio | -0.62 |
| Price to Sales Ratio | 0.76 |
| Price to Cash Ratio | 11.71 |
| Price to Book Ratio | -0.31 |
| Dividend Yield | - |
| Shares Outstanding | 22.45M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.18 (24.31%) |
| Company Name | Biotricity Inc |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://www.biotricity.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
